Please login to the form below

Lucid celebrate big wins at PMEA 2015

Success for Lucid at PMEA 2015

Lucid group successfully supported AbbVie and Genzyme to win two awards at last night’s ceremony in London.

PEER (Psoriasis Expert Exchange FoRum) won the award for Excellence in Physicians/Healthcare Provider Support Programmes. This programme focussed on changing clinical behaviour on a global scale to improve standards of care in the management of psoriatic disease.

Commenting on the award, the judges said “The work around the Psoriasis Expert Exchange FoRum [PEER] showed an excellent understanding of the market and took a patient-centred approach from the outset. This was an ambitious programme reaching 3,200 physicians in 25 countries that achieved behavioural change which resulted in improved patient outcomes. A very comprehensive, sophisticated programme with great penetration. Congratulations to the AbbVie team.”

PEER epitomises Lucid group’s dedication to changing behaviour and improving patient outcomes.

Lucid also supported AbbVie to win the highly commended award in this category for its Treat to Target UK (T2TUK) programme. This programme focussed on driving implementation of the T2TUK recommendations across the UK.
And they celebrated with Genzyme after supporting them to win the award for launch excellence.

Lucid group were also proud to sponsor the award for Excellence in Continuous Development: Education Services for Global or Emerging Markets, which was won by Novo Nordisk for their Changing Diabetes in Children programme.

Dennis O’Brien Lucid group CEO commented 
“we are lucky to have a group of talented clients, who truly work in partnership with us to build programmes that make a difference.  It was great to be able to support them in their work and to celebrate their success with them”

26th November 2015